We are live on ! Find out more
INVA icon

Innoviva

193 hedge funds and large institutions have $1.06B invested in Innoviva in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 60 increasing their positions, 74 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

318% more call options, than puts

Call options by funds: $25.5M | Put options by funds: $6.1M

36% more capital invested

Capital invested by funds: $778M → $1.06B (+$282M)

1.05% more ownership

Funds ownership: 72.89%73.94% (+1%)

8% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 25

4% less funds holding

Funds holding: 201193 (-8)

19% less repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 74

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
193
Holders Change
-8
Holders Change %
-3.98%
% of All Funds
3.8%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
23
Increased
60
Reduced
74
Closed
25
Calls
$25.5M
Puts
$6.1M
Net Calls
+$19.4M
Net Calls Change
+$11.2M

INVA Hedge Fund Activity: Q4 2019 in Review

193 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Innoviva (INVA) for Q4 2019, worth a combined $1.06B — up 36% from $778M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of INVA and 23 opened new positions — a net loss of 2 holders — while 74 trimmed existing stakes and 60 added.

The largest buyer was Arrowstreet Capital, adding an estimated $13.5M. The largest seller was Marshall Wace, cutting an estimated $5.68M.

  • 193 institutional investors held Innoviva (INVA) as of Q4 2019, down from 201 in Q3 2019.
  • Funds reported $1.06B of Innoviva stock for Q4 2019, up 36% quarter-over-quarter.
  • 23 funds opened new Innoviva positions in Q4 2019 and 25 closed out, a net change of -2 holders.
  • The largest Innoviva buyer in Q4 2019 was Arrowstreet Capital, an estimated $13.5M added.
  • The largest Innoviva seller in Q4 2019 was Marshall Wace, an estimated $5.68M sold.

Based on aggregated 13F filings for Q4 2019.